Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 28-Feb 2022. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3993178010 | Product containing precisely lopinavir 40 milligram and ritonavir 10 milligram/1 each conventional release oral pellets in capsule (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 4213772013 | Lopinavir 40 mg and ritonavir 10 mg conventional release oral pellets in capsule | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely lopinavir 40 milligram and ritonavir 10 milligram/1 each conventional release oral pellets in capsule (clinical drug) | Is a | Lopinavir and ritonavir only product in oral dose form | false | Inferred relationship | Some | ||
| Product containing precisely lopinavir 40 milligram and ritonavir 10 milligram/1 each conventional release oral pellets in capsule (clinical drug) | Count of base of active ingredient | 2 (kwalificatiewaarde) | false | Inferred relationship | Some | ||
| Product containing precisely lopinavir 40 milligram and ritonavir 10 milligram/1 each conventional release oral pellets in capsule (clinical drug) | Plays role | Antiretroviral therapeutic role | false | Inferred relationship | Some | ||
| Product containing precisely lopinavir 40 milligram and ritonavir 10 milligram/1 each conventional release oral pellets in capsule (clinical drug) | Has presentation strength numerator unit | mg | false | Inferred relationship | Some | 1 | |
| Product containing precisely lopinavir 40 milligram and ritonavir 10 milligram/1 each conventional release oral pellets in capsule (clinical drug) | Has precise active ingredient | Ritonavir (substance) | false | Inferred relationship | Some | 1 | |
| Product containing precisely lopinavir 40 milligram and ritonavir 10 milligram/1 each conventional release oral pellets in capsule (clinical drug) | Has presentation strength denominator value | 1 (kwalificatiewaarde) | false | Inferred relationship | Some | 1 | |
| Product containing precisely lopinavir 40 milligram and ritonavir 10 milligram/1 each conventional release oral pellets in capsule (clinical drug) | Has basis of strength substance (attribute) | Ritonavir (substance) | false | Inferred relationship | Some | 1 | |
| Product containing precisely lopinavir 40 milligram and ritonavir 10 milligram/1 each conventional release oral pellets in capsule (clinical drug) | Has precise active ingredient | Lopinavir (substance) | false | Inferred relationship | Some | 2 | |
| Product containing precisely lopinavir 40 milligram and ritonavir 10 milligram/1 each conventional release oral pellets in capsule (clinical drug) | Has basis of strength substance (attribute) | Lopinavir (substance) | false | Inferred relationship | Some | 2 | |
| Product containing precisely lopinavir 40 milligram and ritonavir 10 milligram/1 each conventional release oral pellets in capsule (clinical drug) | Has presentation strength denominator value | 1 (kwalificatiewaarde) | false | Inferred relationship | Some | 2 | |
| Product containing precisely lopinavir 40 milligram and ritonavir 10 milligram/1 each conventional release oral pellets in capsule (clinical drug) | Has presentation strength numerator unit | mg | false | Inferred relationship | Some | 2 | |
| Product containing precisely lopinavir 40 milligram and ritonavir 10 milligram/1 each conventional release oral pellets in capsule (clinical drug) | Has manufactured dose form | Conventional release oral pellets in capsule | false | Inferred relationship | Some | ||
| Product containing precisely lopinavir 40 milligram and ritonavir 10 milligram/1 each conventional release oral pellets in capsule (clinical drug) | Has unit of presentation | Capsule (unit of presentation) | false | Inferred relationship | Some | ||
| Product containing precisely lopinavir 40 milligram and ritonavir 10 milligram/1 each conventional release oral pellets in capsule (clinical drug) | Has presentation strength denominator unit (attribute) | Capsule (unit of presentation) | false | Inferred relationship | Some | 1 | |
| Product containing precisely lopinavir 40 milligram and ritonavir 10 milligram/1 each conventional release oral pellets in capsule (clinical drug) | Has presentation strength numerator value | 10 (kwalificatiewaarde) | false | Inferred relationship | Some | 1 | |
| Product containing precisely lopinavir 40 milligram and ritonavir 10 milligram/1 each conventional release oral pellets in capsule (clinical drug) | Has presentation strength numerator value | 40 (kwalificatiewaarde) | false | Inferred relationship | Some | 2 | |
| Product containing precisely lopinavir 40 milligram and ritonavir 10 milligram/1 each conventional release oral pellets in capsule (clinical drug) | Has presentation strength denominator unit (attribute) | Capsule (unit of presentation) | false | Inferred relationship | Some | 2 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Concept inactivation indicator reference set
REPLACED BY association reference set (foundation metadata concept)
FHIR